Connect with us

Health

New COVID-19 variants not in Nigeria, says NCDC

Published

on

The Nigeria Centre for Disease Control and Prevention (NCDC), has said that the COVID-19 Omicron sub-lineages partly responsible for the current increase in COVID-19 cases in China, the United States, and the United Kingdom have not yet been detected in the country.

The NCDC disclosed this on Wednesday in an update on COVID-19 genomic surveillance signed by its Director General, Dr Ifedayo Adetifa.

According to the update, the Omicron sub-lineage responsible for the rise in cases in the US and UK is XBB.1.5 while BF.7 is responsible for the increased cases in China.

Adetifa, however, said B.5.2.1 has been seen in Nigeria since July 2022.

According to him, country-targeted travel restrictions including requests for PCR-negative tests from incoming travellers had little or no effect on preventing global and national circulation of omicron since the emergence of the variant and its relatives with their shorter incubation period.

He said, “The NCDC-led COVID-19 Emergency Operations Centre is monitoring COVID-19 trends in China, the United States of America, the United Kingdom, South Africa, India, and other countries with a high volume of traffic to and from Nigeria. This includes the resurgence of COVID-19 in China following the relaxation of the country’s zero-COVID policy, as well as significantly increased COVID-19 cases, admissions, and deaths in the UK and the USA over the past weeks driven in part by the usual winter exacerbations of respiratory illnesses.

“Before the recent case increase in China, the USA, the UK, and other countries, genomic surveillance has shown that the Omicron SARS-CoV-2 variant and its lineages continue to dominate in recorded infections worldwide. However, the rise in the new Omicron sub-lineages XBB.1.5 in the UK and the US, and BF.7 in China raises concern as it may spread faster than older Omicron sub-lineages (e.g., XBB or BQ) and that they are responsible in part for current increases in cases, hospitalisations, and deaths. However, the sub-lineage seen with cases in China, B.5.2.1, and BF.7 are responsible for the surge in China and do not appear to be increasing unusually in other countries.

“The NCDC continues to strengthen genomic surveillance of the COVID-19 virus in Nigeria. Since the detection of the Omicron variant in December 2021, its sub-lineage (BQ.1/BQ.1.1) has been dominant in Nigeria. None of these dominant sub-lineages in Nigeria that are also circulating elsewhere has been associated with any increases in case numbers, admissions, or deaths locally.

“The sub-lineages partly responsible for the current increase in COVID-19 cases in other countries i.e., XBB.1.5 and BF.7 have not yet been detected in the country but B.5.2.1 has been seen here since July 2022 and the others are most likely here already. BF.7 and XBB have also been circulating in South Africa since October 2022 but without any accompanying increase in cases, severe illness, or deaths.

“The NCDC will continue to pay close attention to the ongoing COVID-19 situation in other countries and gather additional surveillance data to inform actions. We are reviewing the situation again this week. At this next review and if deemed necessary, a range of actions, not limited to enhanced surveillance of travellers at airports, may be decided on and implemented.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Nigerian scientists fail to win FG’s N36m prize for COVID-19, Lassa Fever cure

Published

on

Nigerian scientists and researchers have been unable to claim the N36 million reward offered by the Federal Government for discovering cures for COVID-19 and Lassa Fever, according to checks by DAILY POST. The prize, announced on February 13, 2020, by the then Minister of Science and Technology, Dr. Ogbonnaya Onu, aimed to motivate scientists to find cures for the mentioned diseases. However, as of November 21, 2023, no one has successfully claimed the cash prize.

Dr. Onu had initially challenged Nigerian scientists to find cures for coronavirus and Lassa fever, pledging the N36 million reward for successful discoveries. Despite claims from some individuals and institutions asserting they had found a cure for COVID-19, a committee was set up in May 2020 to review these claims, and the matter seemingly faded away.

The most notable attempt was made by Prof. Maurice Iwu, a former chairman of the Independent National Electoral Commission, who presented a potential cure for COVID-19 in March 2020. However, the cash prize remained unclaimed, and Iwu’s efforts did not lead to the development of a cure for COVID-19.

With the departure of the former minister and the change in administration, the N36 million cash prize appears to have been forgotten. The current director of press and public relations in the Federal Ministry of Innovation, Science, and Technology expressed unawareness of the prize, signaling a lack of continuity in addressing the matter.

Prof. Mosto Onuoha, the President of the Nigerian Academy of Science at the time of the prize announcement, indicated that the issue was inconclusive. He mentioned a lack of clarity in the conceptualization of the cash prize, suggesting that there may not have been a well-defined process for submissions and evaluation.

In conclusion, three years after the announcement, the N36 million cash prize for discovering cures for COVID-19 and Lassa Fever remains unclaimed and seemingly forgotten, raising questions about the transparency and effectiveness of the incentive program.

Continue Reading

Health

China records nearly 13,000 COVID deaths in seven days

Published

on

China reported nearly 13,000 Covid-related deaths in hospitals between January 13 and 19, after a top health official said the vast majority of the population has already been infected by the virus.

China, a week earlier, said nearly 60,000 people had died with Covid in hospitals as of January 12, but there has been widespread scepticism over official data since Beijing abruptly axed anti-virus controls last month.

China’s Center for Disease Control and Prevention (CDC) said in a statement on Saturday that 681 hospitalised patients had died of respiratory failure caused by coronavirus infection, and 11,977 had died of other diseases combined with an infection over the period.

Airfinity, an independent forecasting firm, has estimated daily Covid deaths in China will peak at around 36,000 over the Lunar New Year holiday.

The firm also estimated that more than 600,000 people have died from the disease since China abandoned the zero-Covid policy in December.

An official from the National Health Commission, Guo Yanhong told a news conference on Thursday that China has passed the peak period of Covid patients in fever clinics, emergency rooms and with critical conditions.

Continue Reading

Health

United States To Spend $68m To Fight Malaria In Nigeria

Published

on

The United States has said it plans to spend $68 million to fight malaria in Nigeria.

A document released in Washington DC on Wednesday said the money would be spent under the Presidential Malaria Initiative (PMI).

The funding will support monitoring activities which include insecticide resistance testing in all 11 PMI focus states and five non-PMI focus States.

The benefiary States include Enugu and Kaduna, Abia, Ekiti, Kogi, Kebbi and Sokoto.

“In addition, PMI will continue to support the procurement and distribution of ITNs through mass campaigns, providing technical support to the country’s CY 2024 mass distributions through participation and supporting social and behavior change (SBC) to improve the use and care of ITNs.

“PMI will also maintain the support of streamlined durability monitoring of Interceptor G2 nets (Interceptor G2) in Kebbi State,” the statement said. PMI plans to procure 5.6 million Interceptor G2 for mass campaigns in Oyo State”.

The statement added: “PMI Nigeria will continue to support activities to strengthen malaria in pregnancy (MIP) services and improve uptake of intermittent preventive treatment for pregnant women

“(IPTp), including: strengthening national and state level MIP coordination structures in collaboration with the Ministry of Health (MoH) Reproductive Health (RH) Division; supporting the revision of MIP guidelines, standard operating procedures (SOPs),

‘Training manuals, and job aids to address barriers to uptake of IPTp; and expanding the introduction of the revised guidelines to medical training institutions and other relevant professional associations. PMI will continue to support facility antenatal care (ANC).

“PMI Nigeria will continue to support key case management activities through technical assistance at the federal and state levels, commodity procurement, and facility and community level activities. Activities will include providing updated guidelines for malaria case management, conducting therapeutic efficacy studies, and continuing efforts to establish a national malaria slide bank. With FY 2023 funds, PMI Nigeria will procure 17 million rapid diagnostic test (RDTs), 15 million artemisinin-based combination therapies (ACTs), 350,000 vials of injectable artesunate (IAS), and assorted microscopy supplies, to be distributed to over 5,000 health facilities in the 11 PMI focus states. At the facility level, PMI will continue to support the training of health workers in primary health care (PHC) and secondary health facilities and conduct clinical meetings to increase the quality of malaria case management. At the community level, PMI will expand integrated community case management (iCCM) to four states through the Community Health Influencers, Promoters and Services (CHIPS) Program, including the payment of CHIPS agents,”the statement reads.

Continue Reading

Trending